[Transient diabetes following treatment of acute lymphoblastic leukemia with L-asparaginase].
D000208:Acute Disease; D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D013997:Time Factors
D001215:Asparaginase
Przejściowa cukrzyca po leczeniu L-asparaginaza ostrej białaczki limfoblastycznej